ArdorComm Media Group

Friday, October 23, 2026 2:39 AM

global health alert

India Advises Against Non-Essential Travel to Congo, Uganda and South Sudan Amid Ebola Surge

The Indian government has issued a travel advisory urging citizens to avoid non-essential visits to the Democratic Republic of the Congo, Uganda, and South Sudan following a growing outbreak of Ebola in central Africa. The advisory, released by India’s Health Ministry on May 23, 2026, comes after the World Health Organization classified the outbreak as a global public health emergency. The WHO had earlier designated the situation as a Public Health Emergency of International Concern (PHEIC), citing a “very high” national risk in the DRC and a “high” regional threat level, while maintaining that the global risk remains low. Health authorities confirmed that the ongoing outbreak involves the Bundibugyo strain of Ebola, for which there are currently no approved vaccines or specific treatments. Officials stressed the need for urgent containment measures, including surveillance, contact tracing, and rapid response systems. According to the latest figures released on Saturday, the Ebola outbreak has claimed 216 lives so far, while the total number of confirmed and suspected cases has reached 968. In response, the Directorate General of Health Services (DGHS) has intensified screening measures at major international entry points across India, including Indira Gandhi International Airport. Authorities have introduced targeted monitoring for travellers arriving from or transiting through the affected African nations. Airlines operating on these routes have been instructed to make mandatory health announcements onboard and distribute Self-Declaration Forms (SDFs) to passengers. Travellers displaying symptoms or those who may have come into contact with infected individuals are required to report to Airport Health Officers before immigration clearance. India has also strengthened physical screening measures at airports through round-the-clock thermal scanning and visual surveillance for fever-related symptoms. Dedicated isolation facilities and emergency ambulances have been deployed to ensure immediate transfer of suspected cases to designated hospitals. The Health Ministry further stated that all passengers arriving from high-risk regions must self-monitor their health for 21 days and seek immediate medical attention if symptoms appear, while fully disclosing their recent travel history. The WHO has repeatedly highlighted that Ebola control depends heavily on early detection, swift isolation, public awareness, and community participation. While effective vaccines and monoclonal antibody treatments exist for the Zaire strain of Ebola, the organisation has warned that similar medical countermeasures are not yet available for the rarer Bundibugyo variant. Source: The Hindu

India Advises Against Non-Essential Travel to Congo, Uganda and South Sudan Amid Ebola Surge Read More »

Two Indian Nationals on MV Hondius Show No Symptoms as India Monitors Hantavirus Situation

The Ministry of Health and Family Welfare has confirmed that two Indian nationals currently onboard the cruise ship MV Hondius, where hantavirus cases were reported, are asymptomatic and remain under medical observation under international health guidelines. In an official statement issued Friday, the ministry said it is closely tracking developments and coordinating with the World Health Organization along with other global health bodies. Authorities added that preventive public health steps are being taken to ensure the safety of Indian citizens. According to preliminary information shared through the International Health Regulations (IHR) mechanism, eight probable hantavirus cases have been identified on the vessel so far. Out of these, five have been laboratory confirmed, while three deaths have also been reported. Officials stated that WHO was informed about the outbreak during the first week of May. The two Indian passengers onboard have not shown symptoms and continue to be monitored. The virus involved is reported to be the Andes strain of hantavirus, a variant found in South America that has limited ability for human-to-human transmission. Experts note that transmission generally requires close and prolonged contact. WHO has currently assessed the wider public health risk as low, though more cases may emerge due to the virus’s long incubation period. WHO is also overseeing response measures under IHR protocols, including diagnostic assistance, epidemiological review, and safe travel arrangements for passengers and crew. As a precaution, India’s Public Health Emergency Operations Centre under the National Centre for Disease Control and Integrated Disease Surveillance Programme held a high-level preparedness review meeting. Hantaviruses are commonly spread through rodents such as mice and rats, or through contact with their urine, droppings, or saliva. Symptoms may develop between one and eight weeks after exposure and often include fever, headache, muscle pain, nausea, vomiting, and abdominal discomfort. There is no specific cure for hantavirus infections, but early supportive treatment can improve outcomes by managing respiratory, heart, and kidney complications. Prevention mainly depends on avoiding exposure to infected rodents. Source: The Hindu

Two Indian Nationals on MV Hondius Show No Symptoms as India Monitors Hantavirus Situation Read More »

Chikungunya Risk Grows: WHO Warns of Possible Global Outbreak

The World Health Organization (WHO) has issued a global health alert about the rising threat of a chikungunya epidemic, warning that the virus could soon spread across continents if swift preventive measures are not taken. The warning, issued on Tuesday, highlights signs similar to those observed before the large-scale outbreak of 2004–05. Dr. Diana Rojas Alvarez, a medical officer at the WHO, revealed that approximately 5.6 billion people across 119 countries are potentially vulnerable. Speaking at a press conference in Geneva, she emphasized the virus’s ability to trigger severe fever, debilitating joint pain, and long-lasting health issues, particularly among older adults. Outbreak Timeline and Spread The ongoing surge began in early 2025, primarily affecting regions in the Indian Ocean, including La Réunion, Mayotte, and Mauritius—where nearly one-third of La Réunion’s population has been infected. The virus has since made inroads into Madagascar, Somalia, Kenya, India, and other parts of Southeast Asia. Alarmingly, southern Europe is now reporting isolated locally transmitted cases in France and Italy. Understanding Chikungunya Chikungunya, first identified in Tanzania in 1952, is a mosquito-borne viral illness transmitted mainly by Aedes aegypti and Aedes albopictus mosquitoes. These vectors also spread other diseases like dengue and Zika. Common symptoms include: Sudden onset of high fever Severe joint and muscle pain Headache Fatigue Rash Although the infection is rarely fatal, many patients suffer prolonged joint discomfort that can persist for months. There is currently no specific antiviral treatment. Supportive care—hydration, rest, and pain relief—remains the primary approach. While two vaccines have been approved or recommended in select countries, widespread access and deployment remain limited. The WHO is assessing safety data and global needs to determine the potential for broader rollout. Global Numbers and Trends The European Centre for Disease Prevention and Control (ECDC) reports that, as of June 2025, Brazil leads with over 141,000 cases, followed by Argentina (2,521), Peru (46), and Bolivia (605). The French territory of La Réunion has documented over 51,000 cases by May-end. In South Asia, more than 33,000 infections have been reported in India, Pakistan, and Sri Lanka since June. Notably, regions that were once free from local chikungunya transmission are now witnessing occasional local outbreaks—a shift attributed to global warming and the changing habitats of mosquito species. WHO’s Call to Action To prevent chikungunya from escalating into a full-scale global epidemic, the WHO has urged governments and health agencies to: Enhance mosquito surveillance and vector control Strengthen healthcare infrastructure for better outbreak detection and response Increase public awareness on mosquito bite prevention Accelerate vaccine research and availability The WHO stressed that delaying action now could result in a wider, more difficult-to-control health emergency in the near future. Source: Business Standard

Chikungunya Risk Grows: WHO Warns of Possible Global Outbreak Read More »